JP2020528888A - 心血管器官の病態の予防及び処置における使用のための組成物 - Google Patents

心血管器官の病態の予防及び処置における使用のための組成物 Download PDF

Info

Publication number
JP2020528888A
JP2020528888A JP2020502672A JP2020502672A JP2020528888A JP 2020528888 A JP2020528888 A JP 2020528888A JP 2020502672 A JP2020502672 A JP 2020502672A JP 2020502672 A JP2020502672 A JP 2020502672A JP 2020528888 A JP2020528888 A JP 2020528888A
Authority
JP
Japan
Prior art keywords
composition
iron
lecithin
salt
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020502672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020528888A5 (enExample
Inventor
アンドレア・ラコルテ
ゲルマーノ・タランティーノ
エリザ・ブリッリ
Original Assignee
ファーマヌトゥラ・エッセ・ピ・ア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファーマヌトゥラ・エッセ・ピ・ア filed Critical ファーマヌトゥラ・エッセ・ピ・ア
Publication of JP2020528888A publication Critical patent/JP2020528888A/ja
Publication of JP2020528888A5 publication Critical patent/JP2020528888A5/ja
Priority to JP2023076299A priority Critical patent/JP2023090869A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1592—Iron
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/161—Magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/714—Vitamin K
    • A23V2250/7144—Vitamin K2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2020502672A 2017-07-26 2018-07-26 心血管器官の病態の予防及び処置における使用のための組成物 Pending JP2020528888A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023076299A JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000085412 2017-07-26
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
PCT/IB2018/055586 WO2019021232A1 (en) 2017-07-26 2018-07-26 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023076299A Division JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Publications (2)

Publication Number Publication Date
JP2020528888A true JP2020528888A (ja) 2020-10-01
JP2020528888A5 JP2020528888A5 (enExample) 2021-09-02

Family

ID=60451085

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020502672A Pending JP2020528888A (ja) 2017-07-26 2018-07-26 心血管器官の病態の予防及び処置における使用のための組成物
JP2023076299A Pending JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023076299A Pending JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Country Status (19)

Country Link
US (1) US20200206157A1 (enExample)
EP (1) EP3657963A1 (enExample)
JP (2) JP2020528888A (enExample)
KR (1) KR20200032691A (enExample)
CN (1) CN111031813A (enExample)
BR (1) BR112020000902B1 (enExample)
CA (1) CA3070659A1 (enExample)
CL (1) CL2020000170A1 (enExample)
CO (1) CO2020000526A2 (enExample)
EA (1) EA202090069A1 (enExample)
IL (1) IL272138B2 (enExample)
IT (1) IT201700085412A1 (enExample)
JO (1) JOP20200012A1 (enExample)
MA (1) MA49794A (enExample)
MX (1) MX2020000806A (enExample)
PE (1) PE20200794A1 (enExample)
PH (1) PH12020550031A1 (enExample)
WO (1) WO2019021232A1 (enExample)
ZA (1) ZA202000461B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025510392A (ja) * 2022-03-25 2025-04-14 南京盛徳生物科技研究院有限公司 心血管石灰化を改善するビタミンｋ２を含有する薬物組成物及びその調製方法と応用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
WO2019237054A1 (en) 2018-06-08 2019-12-12 Epizon Pharma, Inc. Methods and compositions for preventing or treating calciphylaxis
SG11202012070YA (en) 2018-06-08 2021-01-28 Epizon Pharma Inc Methods and compositions for preventing or treating tissue calcification
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
EP4531825A1 (en) 2022-05-31 2025-04-09 Region Syddanmark Vitamin k2 for use in treatment of coronary artery calcification

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08253415A (ja) * 1994-04-28 1996-10-01 Eisai Co Ltd 抗動脈硬化治療剤
JP2007523056A (ja) * 2003-10-28 2007-08-16 エモリー ユニバーシティ 透析液並びに透析液に関連した方法及びシステム
JP2009525277A (ja) * 2006-01-30 2009-07-09 グロボアジア エルエルシー 軟組織石灰化の回復、予防、遅延または安定化方法
JP2015523409A (ja) * 2012-07-31 2015-08-13 アレスコ・ソチエタ・ア・レスポンサビリタ・リミタータＡｌｅｓｃｏ ｓ．ｒ．ｌ． 鉄欠乏病状に用いるための鉄を含む固体組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0831728A2 (en) * 1995-06-06 1998-04-01 Campbell Soup Company Mineral supplements for dietetic food
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
US20060134226A1 (en) * 2004-11-16 2006-06-22 Todd Leonard Compositions useful to treat ocular neovascular diseases and macular degeneration
ES2634142T3 (es) * 2005-12-23 2017-09-26 Ajay Gupta Composición de nutrición parenteral que contiene hierro
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
WO2010073642A1 (ja) * 2008-12-25 2010-07-01 有限会社 アイ・ビー・イー 生物活性剤、医薬、化粧品、鮮度保持剤、および植物および動物の発育促進剤
EP2709460A1 (en) * 2011-05-20 2014-03-26 Friesland Brands B.V. Composition comprising vitamin k2
EP2886129A1 (en) * 2013-12-20 2015-06-24 VitaK B.V. Prevention and counteraction of diet-induced thrombosis risk
US20180199610A1 (en) * 2015-02-20 2018-07-19 Vitak B.V. Vitamin k and capillary function
US11344575B2 (en) * 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08253415A (ja) * 1994-04-28 1996-10-01 Eisai Co Ltd 抗動脈硬化治療剤
JP2007523056A (ja) * 2003-10-28 2007-08-16 エモリー ユニバーシティ 透析液並びに透析液に関連した方法及びシステム
JP2009525277A (ja) * 2006-01-30 2009-07-09 グロボアジア エルエルシー 軟組織石灰化の回復、予防、遅延または安定化方法
JP2015523409A (ja) * 2012-07-31 2015-08-13 アレスコ・ソチエタ・ア・レスポンサビリタ・リミタータＡｌｅｓｃｏ ｓ．ｒ．ｌ． 鉄欠乏病状に用いるための鉄を含む固体組成物

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BMC NEPHROLOGY, vol. 18, JPN7022002105, June 2017 (2017-06-01), pages 1 - 10, ISSN: 0004955596 *
HYPERTENSION RESEARCH, vol. 40, JPN7022002104, January 2017 (2017-01-01), pages 562 - 567, ISSN: 0004955598 *
INT. J. MOL. SCI., vol. 16, JPN7022002107, 2015, pages 8861 - 8883, ISSN: 0004955600 *
NUTRITION, vol. 30, JPN6022017506, 2014, pages 739 - 747, ISSN: 0004955597 *
腎と透析, vol. 79, no. 3, JPN7022002106, 2015, pages 452 - 456, ISSN: 0004955599 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025510392A (ja) * 2022-03-25 2025-04-14 南京盛徳生物科技研究院有限公司 心血管石灰化を改善するビタミンｋ２を含有する薬物組成物及びその調製方法と応用

Also Published As

Publication number Publication date
PE20200794A1 (es) 2020-08-10
WO2019021232A1 (en) 2019-01-31
KR20200032691A (ko) 2020-03-26
IL272138A (en) 2020-03-31
ZA202000461B (en) 2021-03-31
IL272138B2 (en) 2023-09-01
IT201700085412A1 (it) 2019-01-26
MA49794A (fr) 2020-06-03
CL2020000170A1 (es) 2020-10-30
CN111031813A (zh) 2020-04-17
US20200206157A1 (en) 2020-07-02
JP2023090869A (ja) 2023-06-29
PH12020550031A1 (en) 2021-02-08
JOP20200012A1 (ar) 2020-01-26
CA3070659A1 (en) 2019-01-31
EP3657963A1 (en) 2020-06-03
CO2020000526A2 (es) 2020-02-18
IL272138B1 (en) 2023-05-01
BR112020000902B1 (pt) 2024-03-12
EA202090069A1 (ru) 2020-04-10
BR112020000902A2 (pt) 2020-07-21
MX2020000806A (es) 2020-08-17

Similar Documents

Publication Publication Date Title
JP2020528888A (ja) 心血管器官の病態の予防及び処置における使用のための組成物
JP6232426B2 (ja) 鉄欠乏病状に用いるための鉄を含む固体組成物
DE60118019T2 (de) Zusammensetzung enthaltend hydroxyzitronensäure und garcinol zur gewichtsreduzierung
Fuster et al. Plant phosphates, phytate and pathological calcifications in chronic kidney disease
JPS61112020A (ja) 抗血栓性並びに抗動脈硬化性高活性を有する薬剤的又は栄養的組成物
US20200246377A1 (en) Composition for use in the prevention and in the treatment of iron deficiency
DE60317639T3 (de) Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren
KR20170015360A (ko) 신장 결석증의 치료 또는 예방을 위한 피트산, 마그네슘 및 폴리페놀을 함유하는 조성물
US20070009590A1 (en) Physiologically active composition based on phosphatidylserine
CN106232143B (zh) 尿酸化剂和结晶抑制剂的组合制剂以及其用于治疗或预防磷酸盐或磷酸钙诱导的肾结石的应用
DE102009012465A1 (de) Pharmazeutische Zusammensetzung zur Prophylaxe und Behandlung der Arteriosklerose, sowie zur Schmerzbekämpfung und zur Entzündungshemmung
KR20220122654A (ko) 미네랄 및/또는 비타민 및 폴리사카라이드를 포함하는 제제, 그 조성물, 및 미네랄 및/또는 비타민 보충에서 그 용도
HU227182B1 (en) Lecitin-ascorbic acid combination
EP2124973B1 (en) Composition comprising omega-3-fatty acids and a masked or coated copper salt
WO2019239372A1 (en) Composition comprising sucrosomial minerals containing mineral salts for use in conditions of deficiency of such minerals
HK40018499A (en) Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
EA046793B1 (ru) Применение композиции (варианты) для профилактического или терапевтического лечения кальцификации сосудов
US20250275982A1 (en) Solid form formulation comprising chromium or copper or a vitamin, compositions and uses thereof
WO2012119049A2 (en) Nutritional compositions comprising prune extract and bioavailable curcumin
JP2012001479A (ja) 水溶性ビタミンｅ含有物より成る生体防御剤
KR20130005770A (ko) 항염증 활성을 갖는 리소포스파티딜에탄올아민 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 항염증 조성물
HK40019663A (en) Solid composition comprising iron for use in iron deficient conditions
JPS6011421A (ja) 血中脂質降下剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210726

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210726

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220427

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220516

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220815

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221014

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230104